Anti-Diabetic Effects of Curcumin-Magnesium Oxide Nanoparticles Conjugate in Type 2 Diabetic Rats

Abstract

Diabetes is a disorder that impairs the ability of the body to process blood glucose. Diabetes is either due to the pancreas produces insufficient amount of insulin or the cells of the body do not react with the insulin produced. Type 2 diabetes (diabetes mellitus) is the most common type of diabetes and grows in prevalence worldwide. The aim of our study was to investigate the antidiabetic impact with emphasis on hepatic lipid metabolism and spleen histopathology effect of curcumin-magnesium oxide nanoparticles conjugate (Cur-MgO NPs conjugate) in nicotinamide (NA)-streptozotocin (STZ) induced type 2 diabetic rats. This study included three groups: Group 1 (control group), Group 2 (STZ induced type 2 diabetic rats) and Group 3 (type 2 diabetic rats were orally administered Cur-MgO NPs conjugate (10 mg/Kg BW/day for 45 days)). The levels of plasma glucose, serum insulin, lipid profile and hepatic expression of lipogenic enzymes Malonyl-CoA decarboxylase (MCD), Peroxisome proliferator-activated receptor alpha (Ppar α) were measured. Moreover, histopathological examination of spleen was carried out. The assessment of Insulin Resistance (HOMA-IR), a significant reduction in serum insulin level and HOMA of β-cell function (HOMA β). Also, reduction in hepatic mRNA expression of MCD and Ppar-α and an altered lipid profile were noticed in diabetic group in comparison with the control group. Oral administration of Cur-MgO NPs conjugate restored glucose (102.73±2.16), TC (139.80±3.61) and LDL-c (87.56±3.72) to their physiological levels in the control group (108.29±2.45, 150.27±2.56 and 94.43±2.75 respectively). Histopathological examination of the spleen showed damage of lymphoid cells in type 2 diabetes (T2D), while in treated group showed moderate improvement in spleen tissue and cells are rescued from apoptosis. The outcome of present study revealed that Cur-MgO NP conjugate has potential ameliorative effect on the hematologic, immunologic and hepatic metabolic alterations in type 2 diabetic rats.

Effects of Dietary Nano-Curcumin Supplementation on Growth Performance, Glucose Metabolism, and Endoplasmic Reticulum Stress in Juvenile Largemouth Bass, Micropterus salmoides

“…To overcome the solubility issues of curcumin and facilitate its intracellular delivery, several approaches have been developed to increase its bioavailability, including liposomal curcumin (Feng et al, 2017), curcumin nanoparticles (Bisht et al, 2007), and curcumin-phospholipid complexes (Maiti et al, 2007). Recent studies showed that nanocurcumin could potentially improve glucose uptake and insulin sensitivity in diabetic mice (Afifi et al, 2020;Shehata et al, 2020). Marchiori et al (2019) showed that the addition of 200 mg/kg curcumin/nanocurcumin can effectively improve the growth performance and liver health of broiler chickens reared under cold stress conditions (Marchiori et al, 2019).…”